The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis

Alan Fauconnier; Tobi E. Nagel; Charlotte Fauconnier; Gilbert Verbeken; Daniel De Vos; Maia Merabishvili; Jean Paul Pirnay

doi:10.3389/fmicb.2020.01982

The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis

Alan Fauconnier, Tobi E. Nagel, Charlotte Fauconnier, Gilbert Verbeken, Daniel De Vos, Maia Merabishvili, Jean Paul Pirnay

Laboratory for Molecular and Cellular Technology

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Aufsatznummer	1982
Fachzeitschrift	Frontiers in Microbiology
Jahrgang	11
DOIs	https://doi.org/10.3389/fmicb.2020.01982
Publikationsstatus	Veröffentlicht - 3 Sept. 2020

Zugriff auf Dokument

10.3389/fmicb.2020.01982

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

@article{c50381ac37f94c3aac54b2bdb3ad87f4,

title = "The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis",

keywords = "GMP, World Health Organization, database, deep learning, local production, low and middle-income countries, phage therapy, regulatory framework",

author = "Alan Fauconnier and Nagel, \{Tobi E.\} and Charlotte Fauconnier and Gilbert Verbeken and \{De Vos\}, Daniel and Maia Merabishvili and Pirnay, \{Jean Paul\}",

year = "2020",

month = sep,

day = "3",

doi = "10.3389/fmicb.2020.01982",

language = "English",

volume = "11",

journal = "Frontiers in Microbiology",

issn = "1664-302X",

}

TY - JOUR

T1 - The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis

AU - Fauconnier, Alan

AU - Nagel, Tobi E.

AU - Fauconnier, Charlotte

AU - Verbeken, Gilbert

AU - De Vos, Daniel

AU - Merabishvili, Maia

AU - Pirnay, Jean Paul

PY - 2020/9/3

Y1 - 2020/9/3

KW - GMP

KW - World Health Organization

KW - database

KW - deep learning

KW - local production

KW - low and middle-income countries

KW - phage therapy

KW - regulatory framework

UR - https://www.scopus.com/pages/publications/85091284661

U2 - 10.3389/fmicb.2020.01982

DO - 10.3389/fmicb.2020.01982

M3 - Article

AN - SCOPUS:85091284661

SN - 1664-302X

VL - 11

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

M1 - 1982

ER -